DE3779221D1
(de)
*
|
1986-08-19 |
1992-06-25 |
Genentech Inc |
Einrichtung und dispersion zum intrapulmonalen eingeben von polypeptidwuchsstoffen und -zytokinen.
|
US5037644A
(en)
*
|
1986-10-27 |
1991-08-06 |
Cetus Corporation |
Pharmaceutical compositions of recombinant interleukin-2 and formulation processes
|
US4944941A
(en)
*
|
1987-08-07 |
1990-07-31 |
Genentech, Inc. |
Methods and compositions for the treatment of lung conditions
|
JP2739733B2
(ja)
*
|
1988-08-09 |
1998-04-15 |
オムロン株式会社 |
吸入器
|
US5198212A
(en)
*
|
1988-10-31 |
1993-03-30 |
University Of Lousville Research Foundation Incorporated |
Method and compositions for treatment of trauma-associated sepsis with gamma interferon
|
EP0377174A3
(de)
*
|
1988-12-22 |
1990-11-22 |
Büsselmann, Manfred |
Verfahren und Vorrichtung zum Zerstäuben und Vernebeln von flüssigen Stoffen
|
US4994439A
(en)
*
|
1989-01-19 |
1991-02-19 |
California Biotechnology Inc. |
Transmembrane formulations for drug administration
|
US5011678A
(en)
*
|
1989-02-01 |
1991-04-30 |
California Biotechnology Inc. |
Composition and method for administration of pharmaceutically active substances
|
JPH05963A
(ja)
*
|
1990-04-13 |
1993-01-08 |
Toray Ind Inc |
ポリペプチド類組成物
|
ATE113469T1
(de)
*
|
1990-06-21 |
1994-11-15 |
Edith Dr Huland |
Verwendung zytokinhaltiger aerosole und zytokinhaltige aerosole selbst.
|
US5780012A
(en)
*
|
1990-06-21 |
1998-07-14 |
Huland; Edith |
Method for reducing lung afflictions by inhalation of cytokine solutions
|
US6565841B1
(en)
|
1991-03-15 |
2003-05-20 |
Amgen, Inc. |
Pulmonary administration of granulocyte colony stimulating factor
|
DE4117078A1
(de)
*
|
1991-05-25 |
1992-11-26 |
Boehringer Ingelheim Kg |
Verfahren zur herstellung therapeutisch anwendbarer aerosole
|
US6673335B1
(en)
|
1992-07-08 |
2004-01-06 |
Nektar Therapeutics |
Compositions and methods for the pulmonary delivery of aerosolized medicaments
|
US6024090A
(en)
*
|
1993-01-29 |
2000-02-15 |
Aradigm Corporation |
Method of treating a diabetic patient by aerosolized administration of insulin lispro
|
US7448375B2
(en)
*
|
1993-01-29 |
2008-11-11 |
Aradigm Corporation |
Method of treating diabetes mellitus in a patient
|
US5354934A
(en)
†
|
1993-02-04 |
1994-10-11 |
Amgen Inc. |
Pulmonary administration of erythropoietin
|
IL109350A
(en)
*
|
1993-05-12 |
2001-01-28 |
Genentech Inc |
Stable liquid preparations of gamma interferon
|
US5497763A
(en)
*
|
1993-05-21 |
1996-03-12 |
Aradigm Corporation |
Disposable package for intrapulmonary delivery of aerosolized formulations
|
US5512269A
(en)
*
|
1993-06-09 |
1996-04-30 |
Burroughs Wellcome, Co. |
Method of treating retained pulmonary secretions
|
ES2218543T3
(es)
*
|
1994-03-07 |
2004-11-16 |
Nektar Therapeutics |
Procedimiento y preparacion para la administracion de insulina por via pulmonar.
|
US20030113273A1
(en)
*
|
1996-06-17 |
2003-06-19 |
Patton John S. |
Methods and compositions for pulmonary delivery of insulin
|
US6290991B1
(en)
|
1994-12-02 |
2001-09-18 |
Quandrant Holdings Cambridge Limited |
Solid dose delivery vehicle and methods of making same
|
US5522385A
(en)
*
|
1994-09-27 |
1996-06-04 |
Aradigm Corporation |
Dynamic particle size control for aerosolized drug delivery
|
US6428771B1
(en)
*
|
1995-05-15 |
2002-08-06 |
Pharmaceutical Discovery Corporation |
Method for drug delivery to the pulmonary system
|
US5972331A
(en)
*
|
1995-12-22 |
1999-10-26 |
Schering Corporation |
Crystalline interferon alpha for pulmonary delivery and method for producing the same
|
US5874064A
(en)
|
1996-05-24 |
1999-02-23 |
Massachusetts Institute Of Technology |
Aerodynamically light particles for pulmonary drug delivery
|
US6652837B1
(en)
|
1996-05-24 |
2003-11-25 |
Massachusetts Institute Of Technology |
Preparation of novel particles for inhalation
|
US6565885B1
(en)
|
1997-09-29 |
2003-05-20 |
Inhale Therapeutic Systems, Inc. |
Methods of spray drying pharmaceutical compositions
|
US20060165606A1
(en)
|
1997-09-29 |
2006-07-27 |
Nektar Therapeutics |
Pulmonary delivery particles comprising water insoluble or crystalline active agents
|
US6455283B1
(en)
|
1998-03-17 |
2002-09-24 |
Genentech, Inc. |
Nucleic acids encoding vascular endothelial cell growth factor-E (VEGF-E)
|
SE9803770D0
(sv)
*
|
1998-11-05 |
1998-11-05 |
Astra Ab |
Dry powder pharmaceutical formulation
|
DE19851380A1
(de)
*
|
1998-11-07 |
2000-05-11 |
Messer Griesheim Gmbh |
Parfümierung von Sauerstoff
|
WO2001000832A1
(en)
|
1999-06-28 |
2001-01-04 |
Genentech, Inc. |
Methods for making apo-2 ligand using divalent metal ions
|
US6444226B1
(en)
*
|
1999-06-29 |
2002-09-03 |
Pharmaceutical Discovery Corporation |
Purification and stabilization of peptide and protein pharmaceutical agents
|
US9006175B2
(en)
|
1999-06-29 |
2015-04-14 |
Mannkind Corporation |
Potentiation of glucose elimination
|
US7678364B2
(en)
|
1999-08-25 |
2010-03-16 |
Alkermes, Inc. |
Particles for inhalation having sustained release properties
|
US6749835B1
(en)
|
1999-08-25 |
2004-06-15 |
Advanced Inhalation Research, Inc. |
Formulation for spray-drying large porous particles
|
JP3852256B2
(ja)
|
1999-11-10 |
2006-11-29 |
富士ゼロックス株式会社 |
インクジェット記録装置
|
JP2001187459A
(ja)
|
1999-12-28 |
2001-07-10 |
Fuji Xerox Co Ltd |
インクジェット記録装置
|
ATE319424T1
(de)
*
|
1999-12-30 |
2006-03-15 |
Intermune Inc |
Gamma-ifn flüssigtropfenaerosol und verfahren
|
DE60141680D1
(de)
*
|
2000-01-14 |
2010-05-12 |
Univ Brown Res Found |
Verfahren zur herstellung von mikronisierte gefriergetrocknete partikeln
|
AU783120B2
(en)
*
|
2000-01-25 |
2005-09-29 |
Aeropharm Technology, Inc. |
A medicinal aerosol formulation
|
US6585957B1
(en)
|
2000-01-25 |
2003-07-01 |
Aeropharm Technology Incorporated |
Medicinal aerosol formulation
|
US8404217B2
(en)
|
2000-05-10 |
2013-03-26 |
Novartis Ag |
Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
|
US7871598B1
(en)
|
2000-05-10 |
2011-01-18 |
Novartis Ag |
Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
|
ES2525087T5
(es)
|
2000-05-10 |
2018-06-28 |
Novartis Ag |
Polvos basados en fosfolípidos para administración de fármacos
|
EP2042597B1
(de)
|
2000-06-23 |
2014-05-07 |
Genentech, Inc. |
Zusammensetzungen und Verfahren zur Diagnose und Behandlung von Erkrankungen in Verbindung mit Angiogenese
|
CA2648048A1
(en)
|
2000-06-23 |
2002-01-03 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
|
CN1446077A
(zh)
*
|
2000-08-07 |
2003-10-01 |
耐科塔医药公司 |
具有最小聚集的可吸入喷雾干燥4-螺旋束蛋白粉剂
|
JP4931282B2
(ja)
*
|
2000-10-02 |
2012-05-16 |
日本ケミカルリサーチ株式会社 |
生理活性ペプチド含有粉末
|
WO2002039914A1
(en)
*
|
2000-11-15 |
2002-05-23 |
Scimed Life Systems, Inc. |
Device and method for treating female urinary incontinence
|
AU2002230993B2
(en)
|
2000-12-29 |
2006-02-02 |
Alkermes, Inc. |
Particles for inhalation having sustained release properties
|
WO2003029462A1
(en)
*
|
2001-09-27 |
2003-04-10 |
Pieris Proteolab Ag |
Muteins of human neutrophil gelatinase-associated lipocalin and related proteins
|
EP1430136A1
(de)
*
|
2001-09-27 |
2004-06-23 |
Pieris ProteoLab AG |
Apolipoprotein d muteine
|
JP2005508162A
(ja)
|
2001-10-02 |
2005-03-31 |
ジェネンテック・インコーポレーテッド |
Apo−2リガンド変異体とその使用法
|
ES2351786T3
(es)
|
2001-11-13 |
2011-02-10 |
Genentech, Inc. |
Formulaciones con ligando apo2/trail y usos de las mismas.
|
SI1458360T1
(sl)
|
2001-12-19 |
2011-08-31 |
Novartis Ag |
Pulmonalno dajanje aminoglikozidov
|
CN100352715C
(zh)
|
2001-12-27 |
2007-12-05 |
日本精工株式会社 |
车辆用可倾斜式转向装置
|
US20040063912A1
(en)
*
|
2002-03-15 |
2004-04-01 |
The Brigham And Women's Hospital, Inc. |
Central airway administration for systemic delivery of therapeutics
|
US7008644B2
(en)
*
|
2002-03-20 |
2006-03-07 |
Advanced Inhalation Research, Inc. |
Method and apparatus for producing dry particles
|
US20050163725A1
(en)
*
|
2002-03-20 |
2005-07-28 |
Blizzard Charles D. |
Method for administration of growth hormone via pulmonary delivery
|
CA2478801A1
(en)
*
|
2002-03-20 |
2003-10-02 |
Advanced Inhalation Research, Inc. |
Method for administration of growth hormone via pulmonary delivery
|
AU2003220125B2
(en)
|
2002-03-20 |
2006-06-15 |
Mannkind Corporation |
Inhalation apparatus
|
EP2305710A3
(de)
|
2002-06-03 |
2013-05-29 |
Genentech, Inc. |
Synthetische Antikörperphagenbibliotheken
|
WO2004001009A2
(en)
|
2002-06-24 |
2003-12-31 |
Genentech, Inc. |
Apo-2 ligand/trail variants and uses thereof
|
ATE429441T1
(de)
*
|
2002-07-08 |
2009-05-15 |
Glaxosmithkline Zagreb |
Hybridmoleküle von makroliden mit steroidalen/nicht-steroidalen antientzündlich aktiven molekülen
|
JP4790263B2
(ja)
*
|
2002-07-08 |
2011-10-12 |
グラクソ グループ リミテッド |
炎症性の疾患および病態を治療する新規な化合物、組成物および方法
|
DE60336406D1
(de)
|
2002-10-16 |
2011-04-28 |
Purdue Pharma Lp |
Antikörper, die an zellassoziiertes ca 125/0722p binden, und verfahren zu deren anwendung
|
HRP20030324A2
(en)
|
2003-04-24 |
2005-02-28 |
Pliva-Istra�iva�ki institut d.o.o. |
Compounds of antiinflammatory effect
|
US7338171B2
(en)
*
|
2003-10-27 |
2008-03-04 |
Jen-Chuen Hsieh |
Method and apparatus for visual drive control
|
KR100985126B1
(ko)
*
|
2004-01-12 |
2010-10-05 |
맨카인드 코포레이션 |
제2형 당뇨병에서 혈청 프로인슐린 수치의 감소 방법
|
US20080090753A1
(en)
*
|
2004-03-12 |
2008-04-17 |
Biodel, Inc. |
Rapid Acting Injectable Insulin Compositions
|
PT2319500E
(pt)
*
|
2004-03-12 |
2013-01-23 |
Biodel Inc |
Composições de distribuição de fármacos de actuação rápida
|
PL1786784T3
(pl)
|
2004-08-20 |
2011-04-29 |
Mannkind Corp |
Kataliza syntezy diketopiperazyn
|
EP2322180B1
(de)
|
2004-08-23 |
2015-05-27 |
MannKind Corporation |
Diketopiperazinsalze zur Arzneimitteldarreichung
|
EP2196469A1
(de)
|
2004-10-27 |
2010-06-16 |
GlaxoSmithKline istrazivacki centar Zagreb d.o.o. |
Konjugate mit entzündungshemmender Wirkung
|
WO2006055950A1
(en)
*
|
2004-11-18 |
2006-05-26 |
Nektar Therapeutics |
Pharmaceutical dry powder formulation on the basis particles comprising multiple active agents
|
MX2007007345A
(es)
*
|
2004-12-17 |
2007-09-07 |
Glenmark Pharmaceuticals Sa |
Compuestos heterociclicos novedosos utiles para el tratamiento de trastornos inflamatorios y alergicos.
|
SI1831227T1
(sl)
*
|
2004-12-17 |
2013-09-30 |
Glenmark Pharmaceuticals S.A. |
Nove heterociklične spojine uporabne za zdravljenje vnetnih in alergijskih motenj
|
RU2390325C2
(ru)
|
2005-09-14 |
2010-05-27 |
Маннкайнд Корпорейшн |
Способ приготовления лекарственного препарата, основанный на увеличении сродства активных агентов к поверхностям кристаллических микрочастиц
|
US20070086952A1
(en)
*
|
2005-09-29 |
2007-04-19 |
Biodel, Inc. |
Rapid Acting and Prolonged Acting Inhalable Insulin Preparations
|
US7713929B2
(en)
|
2006-04-12 |
2010-05-11 |
Biodel Inc. |
Rapid acting and long acting insulin combination formulations
|
US8084420B2
(en)
*
|
2005-09-29 |
2011-12-27 |
Biodel Inc. |
Rapid acting and long acting insulin combination formulations
|
RU2403059C2
(ru)
|
2006-02-22 |
2010-11-10 |
Маннкайнд Корпорейшн |
Способ улучшения фармацевтических свойств микрочастиц, содержащих дикетопиперазин и активный агент
|
US7718609B2
(en)
*
|
2006-04-12 |
2010-05-18 |
Biodel Inc. |
Rapid acting and long acting insulin combination formulations
|
GB0617417D0
(en)
*
|
2006-09-05 |
2006-10-18 |
Concept 2 Manufacture Design L |
A nebuliser valve
|
WO2008124522A2
(en)
*
|
2007-04-04 |
2008-10-16 |
Biodel, Inc. |
Amylin formulations
|
CN101951957A
(zh)
*
|
2008-01-04 |
2011-01-19 |
百达尔公司 |
胰岛素释放作为组织的葡萄糖水平的函数的胰岛素制剂
|
JP4654266B2
(ja)
*
|
2008-05-14 |
2011-03-16 |
株式会社群馬コイケ |
ネブライザー
|
US8636001B2
(en)
|
2008-06-13 |
2014-01-28 |
Mannkind Corporation |
Dry powder inhaler and system for drug delivery
|
US8485180B2
(en)
|
2008-06-13 |
2013-07-16 |
Mannkind Corporation |
Dry powder drug delivery system
|
DK2609954T3
(da)
|
2008-06-20 |
2022-02-14 |
Mannkind Corp |
Interaktivt apparat til realtidsafbildning af inhalationspræstationer
|
TWI614024B
(zh)
|
2008-08-11 |
2018-02-11 |
曼凱公司 |
超快起作用胰島素之用途
|
BRPI0913476A2
(pt)
|
2008-09-10 |
2015-12-01 |
Genentech Inc |
"usos de um antagonista tspan12 e usos de um antagonista de norrin"
|
JP2012504969A
(ja)
|
2008-10-10 |
2012-03-01 |
アナフォア インコーポレイテッド |
Trail−r1及びtrail−r2に結合するポリペプチド
|
US8314106B2
(en)
|
2008-12-29 |
2012-11-20 |
Mannkind Corporation |
Substituted diketopiperazine analogs for use as drug delivery agents
|
US9060927B2
(en)
*
|
2009-03-03 |
2015-06-23 |
Biodel Inc. |
Insulin formulations for rapid uptake
|
EP2405963B1
(de)
|
2009-03-11 |
2013-11-06 |
MannKind Corporation |
Gerät, system und verfahren zur messung von widerstand in einem inhaliergerät
|
EP2260857A1
(de)
|
2009-06-11 |
2010-12-15 |
Alfact Innovation |
Neuartige Anwendungen von HIP/PAP und Derivate davon
|
CN102647979B
(zh)
|
2009-06-12 |
2015-03-04 |
曼金德公司 |
具有确定比表面积的二酮哌嗪颗粒
|
EP2496295A1
(de)
|
2009-11-03 |
2012-09-12 |
MannKind Corporation |
Vorrichtung und verfahren zur simulation von einatmungsanstrengungen
|
DK2510357T3
(en)
|
2009-12-07 |
2016-07-18 |
Pieris Ag |
MUTEINS OF HUMAN LIPOCALIN 2 (LCN2, HNGAL) WITH AFFINITY FOR A SPECIFIC TARGET
|
EP2582421A1
(de)
|
2010-06-21 |
2013-04-24 |
MannKind Corporation |
System und verfahren zur verabreichung von arzneimitteln in trockenpulverform
|
EP2683368A1
(de)
|
2011-03-10 |
2014-01-15 |
F.Hoffmann-La Roche Ag |
Behandlung von erkrankungen mit veränderter gefässbarrierefunktion
|
WO2012135765A2
(en)
|
2011-04-01 |
2012-10-04 |
Mannkind Corporation |
Blister package for pharmaceutical cartridges
|
CA2834776A1
(en)
|
2011-05-03 |
2012-11-08 |
Genentech, Inc. |
Therapeutic apo2l/trail polypeptides and death receptor agonist antibodies
|
WO2012174472A1
(en)
|
2011-06-17 |
2012-12-20 |
Mannkind Corporation |
High capacity diketopiperazine microparticles
|
CN103945859A
(zh)
|
2011-10-24 |
2014-07-23 |
曼金德公司 |
用于治疗疼痛的方法和组合物
|
US9802012B2
(en)
|
2012-07-12 |
2017-10-31 |
Mannkind Corporation |
Dry powder drug delivery system and methods
|
EP2687225A1
(de)
|
2012-07-19 |
2014-01-22 |
Alfact Innovation |
HIP/PAP-Protein und Derivate davon zur Verwendung bei der Behandlung von Krebs
|
US10159644B2
(en)
|
2012-10-26 |
2018-12-25 |
Mannkind Corporation |
Inhalable vaccine compositions and methods
|
EP3441400B1
(de)
|
2012-11-19 |
2022-07-20 |
Pieris Pharmaceuticals GmbH |
Neuartige polypeptide mit spezifischer bindung und verwendungen davon
|
SG11201507564PA
(en)
|
2013-03-15 |
2015-10-29 |
Mannkind Corp |
Microcrystalline diketopiperazine compositions and methods
|
MX2020009878A
(es)
|
2013-07-18 |
2022-07-27 |
Mannkind Corp |
Composiciones farmaceuticas en polvo seco estables al calor y metodos.
|
EP3030294B1
(de)
|
2013-08-05 |
2020-10-07 |
MannKind Corporation |
Insufflationsvorrichtung
|
US10927154B2
(en)
|
2014-01-13 |
2021-02-23 |
Pieris Pharmaceuticals Gmbh |
Multi-specific polypeptide useful for localized tumor immunomodulation
|
US10307464B2
(en)
|
2014-03-28 |
2019-06-04 |
Mannkind Corporation |
Use of ultrarapid acting insulin
|
CA2888068A1
(en)
|
2014-04-15 |
2015-10-15 |
The Hospital For Sick Children |
Cationic antimicrobial peptides
|
RU2723034C2
(ru)
|
2014-05-22 |
2020-06-08 |
ПИЕРИС ФАРМАСЬЮТИКАЛС ГмбХ |
Новые полипептиды со специфическим связыванием и пути их применения
|
US10561806B2
(en)
|
2014-10-02 |
2020-02-18 |
Mannkind Corporation |
Mouthpiece cover for an inhaler
|
SG10201906859PA
(en)
|
2015-01-28 |
2019-08-27 |
Pieris Pharmaceuticals Gmbh |
Novel proteins specific for angiogenesis
|
MX2017014082A
(es)
|
2015-05-04 |
2018-06-28 |
Pieris Pharmaceuticals Gmbh |
Nuevas proteinas especificas para cd137.
|
KR20170138574A
(ko)
|
2015-05-04 |
2017-12-15 |
피어이스 파마슈티컬즈 게엠베하 |
항암 융합 폴리펩타이드
|
CA2980838A1
(en)
|
2015-05-18 |
2016-11-24 |
Pieris Pharmaceuticals Gmbh |
Anti-cancer fusion polypeptide
|
BR112017020961A2
(pt)
|
2015-05-18 |
2018-07-10 |
Pieris Pharmaceuticals Gmbh |
muteína, molécula de ácido nucleico, célula hospedeira, método de produção de uma muteína e método de ligação
|
JP2019505565A
(ja)
|
2015-11-30 |
2019-02-28 |
ピエリス オーストラリア プロプライエタリー リミテッド |
新規の抗血管新生融合ポリペプチド
|
TW201725212A
(zh)
|
2015-12-10 |
2017-07-16 |
第一三共股份有限公司 |
特異性於降鈣素基因相關胜肽的新穎蛋白
|
WO2023111664A1
(en)
*
|
2021-12-19 |
2023-06-22 |
Kamagtech Bio Pharma |
Device and method for use in treatment of pathogens
|